Cite
Long-term surveillance of biologic therapies in systemic-onset juvenile idiopathic arthritis: data from the German BIKER registry.
MLA
Klein, Ariane, et al. “Long-Term Surveillance of Biologic Therapies in Systemic-Onset Juvenile Idiopathic Arthritis: Data from the German BIKER Registry.” Rheumatology (Oxford, England), vol. 59, no. 9, Sept. 2020, pp. 2287–98. EBSCOhost, https://doi.org/10.1093/rheumatology/kez577.
APA
Klein, A., Klotsche, J., Hügle, B., Minden, K., Hospach, A., Weller-Heinemann, F., Schwarz, T., Dressler, F., Trauzeddel, R., Hufnagel, M., Foeldvari, I., Borte, M., Kuemmerle-Deschner, J., Brunner, J., Oommen, P. T., Föll, D., Tenbrock, K., Urban, A., & Horneff, G. (2020). Long-term surveillance of biologic therapies in systemic-onset juvenile idiopathic arthritis: data from the German BIKER registry. Rheumatology (Oxford, England), 59(9), 2287–2298. https://doi.org/10.1093/rheumatology/kez577
Chicago
Klein, Ariane, Jens Klotsche, Boris Hügle, Kirsten Minden, Anton Hospach, Frank Weller-Heinemann, Tobias Schwarz, et al. 2020. “Long-Term Surveillance of Biologic Therapies in Systemic-Onset Juvenile Idiopathic Arthritis: Data from the German BIKER Registry.” Rheumatology (Oxford, England) 59 (9): 2287–98. doi:10.1093/rheumatology/kez577.